NO326796B1 - Naeringsmiddel- eller dyrefôrsammensetning som innheholder planteekstrakt for a forebygge benresorpsjon og fremme bendannelse samt anvendelse av en plante eller planteekstrakt - Google Patents
Naeringsmiddel- eller dyrefôrsammensetning som innheholder planteekstrakt for a forebygge benresorpsjon og fremme bendannelse samt anvendelse av en plante eller planteekstrakt Download PDFInfo
- Publication number
- NO326796B1 NO326796B1 NO20042150A NO20042150A NO326796B1 NO 326796 B1 NO326796 B1 NO 326796B1 NO 20042150 A NO20042150 A NO 20042150A NO 20042150 A NO20042150 A NO 20042150A NO 326796 B1 NO326796 B1 NO 326796B1
- Authority
- NO
- Norway
- Prior art keywords
- bone
- plant
- amelanchier
- plant extract
- mixture
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 73
- 239000000419 plant extract Substances 0.000 title claims description 28
- 208000006386 Bone Resorption Diseases 0.000 title claims description 21
- 230000024279 bone resorption Effects 0.000 title claims description 21
- 230000011164 ossification Effects 0.000 title claims description 18
- 235000015097 nutrients Nutrition 0.000 title claims description 7
- 241001465754 Metazoa Species 0.000 title description 3
- 230000002265 prevention Effects 0.000 claims abstract description 3
- 235000013305 food Nutrition 0.000 claims description 44
- 241000196324 Embryophyta Species 0.000 claims description 33
- 210000000988 bone and bone Anatomy 0.000 claims description 18
- 230000000694 effects Effects 0.000 claims description 16
- 241001092083 Amelanchier Species 0.000 claims description 12
- 235000015872 dietary supplement Nutrition 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 10
- 206010065687 Bone loss Diseases 0.000 claims description 9
- 235000013406 prebiotics Nutrition 0.000 claims description 9
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 8
- 239000011707 mineral Substances 0.000 claims description 8
- 244000298479 Cichorium intybus Species 0.000 claims description 6
- 235000007542 Cichorium intybus Nutrition 0.000 claims description 6
- 235000013399 edible fruits Nutrition 0.000 claims description 6
- 244000137121 Amelanchier vulgaris Species 0.000 claims description 5
- 235000001311 Amelanchier vulgaris Nutrition 0.000 claims description 5
- 244000068687 Amelanchier alnifolia Species 0.000 claims description 4
- 235000009027 Amelanchier alnifolia Nutrition 0.000 claims description 4
- 208000010392 Bone Fractures Diseases 0.000 claims description 4
- 206010017076 Fracture Diseases 0.000 claims description 4
- 230000010478 bone regeneration Effects 0.000 claims description 4
- 210000000845 cartilage Anatomy 0.000 claims description 4
- 230000012010 growth Effects 0.000 claims description 4
- 230000035876 healing Effects 0.000 claims description 4
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 claims description 3
- 229920001287 Chondroitin sulfate Polymers 0.000 claims description 3
- 244000269722 Thea sinensis Species 0.000 claims description 3
- 244000299461 Theobroma cacao Species 0.000 claims description 3
- 235000009470 Theobroma cacao Nutrition 0.000 claims description 3
- 239000003963 antioxidant agent Substances 0.000 claims description 3
- 235000006708 antioxidants Nutrition 0.000 claims description 3
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims description 3
- 230000000975 bioactive effect Effects 0.000 claims description 3
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 3
- 239000000194 fatty acid Substances 0.000 claims description 3
- 229930195729 fatty acid Natural products 0.000 claims description 3
- 150000004665 fatty acids Chemical class 0.000 claims description 3
- 229960002442 glucosamine Drugs 0.000 claims description 3
- 201000008482 osteoarthritis Diseases 0.000 claims description 3
- 235000013616 tea Nutrition 0.000 claims description 3
- 244000304226 Amelanchier arborea Species 0.000 claims description 2
- 235000007084 Amelanchier arborea Nutrition 0.000 claims description 2
- 244000304227 Amelanchier asiatica Species 0.000 claims description 2
- 235000007086 Amelanchier asiatica Nutrition 0.000 claims description 2
- 240000004445 Amelanchier laevis Species 0.000 claims description 2
- 235000007092 Amelanchier laevis Nutrition 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims description 2
- 208000024891 symptom Diseases 0.000 claims description 2
- 238000005457 optimization Methods 0.000 claims 1
- 235000016709 nutrition Nutrition 0.000 abstract description 15
- 239000000047 product Substances 0.000 abstract description 7
- 239000003814 drug Substances 0.000 abstract description 6
- 238000000034 method Methods 0.000 abstract description 6
- 230000008468 bone growth Effects 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 208000020084 Bone disease Diseases 0.000 abstract description 4
- 230000037180 bone health Effects 0.000 abstract description 4
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 238000012423 maintenance Methods 0.000 abstract 2
- 239000013589 supplement Substances 0.000 abstract 1
- 239000000284 extract Substances 0.000 description 28
- 108010049931 Bone Morphogenetic Protein 2 Proteins 0.000 description 8
- 102100024506 Bone morphogenetic protein 2 Human genes 0.000 description 8
- 241000282412 Homo Species 0.000 description 7
- 241000245665 Taraxacum Species 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 239000003925 fat Substances 0.000 description 7
- 235000019197 fats Nutrition 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 241000282472 Canis lupus familiaris Species 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 241000124008 Mammalia Species 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 235000012054 meals Nutrition 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 239000006041 probiotic Substances 0.000 description 5
- 230000000529 probiotic effect Effects 0.000 description 5
- 235000018291 probiotics Nutrition 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Natural products OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 108010010256 Dietary Proteins Proteins 0.000 description 3
- 102000015781 Dietary Proteins Human genes 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 108060001084 Luciferase Proteins 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 235000015496 breakfast cereal Nutrition 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 235000005822 corn Nutrition 0.000 description 3
- 235000021245 dietary protein Nutrition 0.000 description 3
- 229940011871 estrogen Drugs 0.000 description 3
- 239000000262 estrogen Substances 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 210000002997 osteoclast Anatomy 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 235000014214 soft drink Nutrition 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 102000000589 Interleukin-1 Human genes 0.000 description 2
- 108010002352 Interleukin-1 Proteins 0.000 description 2
- 239000005089 Luciferase Substances 0.000 description 2
- 108010011756 Milk Proteins Proteins 0.000 description 2
- 102000014171 Milk Proteins Human genes 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- 108090000445 Parathyroid hormone Proteins 0.000 description 2
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 2
- 102000007591 Tartrate-Resistant Acid Phosphatase Human genes 0.000 description 2
- 108010032050 Tartrate-Resistant Acid Phosphatase Proteins 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000021239 milk protein Nutrition 0.000 description 2
- 239000008177 pharmaceutical agent Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000001253 polyvinylpolypyrrolidone Substances 0.000 description 2
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 2
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- OGSPWJRAVKPPFI-UHFFFAOYSA-N Alendronic Acid Chemical compound NCCCC(O)(P(O)(O)=O)P(O)(O)=O OGSPWJRAVKPPFI-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 229940122361 Bisphosphonate Drugs 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 102000055006 Calcitonin Human genes 0.000 description 1
- 108060001064 Calcitonin Proteins 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 102000004171 Cathepsin K Human genes 0.000 description 1
- 108090000625 Cathepsin K Proteins 0.000 description 1
- 102000005575 Cellulases Human genes 0.000 description 1
- 108010084185 Cellulases Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 239000004097 EU approved flavor enhancer Substances 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 108700039887 Essential Genes Proteins 0.000 description 1
- 239000001422 FEMA 4092 Substances 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
- 208000012659 Joint disease Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 108010070551 Meat Proteins Proteins 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- PCZOHLXUXFIOCF-UHFFFAOYSA-N Monacolin X Natural products C12C(OC(=O)C(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 PCZOHLXUXFIOCF-UHFFFAOYSA-N 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 102000003982 Parathyroid hormone Human genes 0.000 description 1
- 102100036893 Parathyroid hormone Human genes 0.000 description 1
- 108010084695 Pea Proteins Proteins 0.000 description 1
- 102000015731 Peptide Hormones Human genes 0.000 description 1
- 108010038988 Peptide Hormones Proteins 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 description 1
- 108050003267 Prostaglandin G/H synthase 2 Proteins 0.000 description 1
- 102000014128 RANK Ligand Human genes 0.000 description 1
- 108010025832 RANK Ligand Proteins 0.000 description 1
- IIDJRNMFWXDHID-UHFFFAOYSA-N Risedronic acid Chemical compound OP(=O)(O)C(P(O)(O)=O)(O)CC1=CC=CN=C1 IIDJRNMFWXDHID-UHFFFAOYSA-N 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 1
- 229920001938 Vegetable gum Polymers 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940062527 alendronate Drugs 0.000 description 1
- 102000016679 alpha-Glucosidases Human genes 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000000123 anti-resoprtive effect Effects 0.000 description 1
- 235000008452 baby food Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 150000004663 bisphosphonates Chemical class 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000002449 bone cell Anatomy 0.000 description 1
- 231100001018 bone marrow damage Toxicity 0.000 description 1
- 230000010072 bone remodeling Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 238000010805 cDNA synthesis kit Methods 0.000 description 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
- 229960004015 calcitonin Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002357 endometrial effect Effects 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 235000019264 food flavour enhancer Nutrition 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 231100000508 hormonal effect Toxicity 0.000 description 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000003049 inorganic solvent Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 235000014666 liquid concentrate Nutrition 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- PCZOHLXUXFIOCF-BXMDZJJMSA-N lovastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 PCZOHLXUXFIOCF-BXMDZJJMSA-N 0.000 description 1
- 229960004844 lovastatin Drugs 0.000 description 1
- QLJODMDSTUBWDW-UHFFFAOYSA-N lovastatin hydroxy acid Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(C)C=C21 QLJODMDSTUBWDW-UHFFFAOYSA-N 0.000 description 1
- 238000003670 luciferase enzyme activity assay Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 235000021243 milk fat Nutrition 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 239000000199 parathyroid hormone Substances 0.000 description 1
- 229960001319 parathyroid hormone Drugs 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 235000010603 pastilles Nutrition 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 235000019702 pea protein Nutrition 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000000813 peptide hormone Substances 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 235000017807 phytochemicals Nutrition 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229940089617 risedronate Drugs 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 102000003298 tumor necrosis factor receptor Human genes 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Polymers & Plastics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Physical Education & Sports Medicine (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Molecular Biology (AREA)
- Birds (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Immunology (AREA)
- Fodder In General (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Feed For Specific Animals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01204839A EP1325682A1 (de) | 2001-12-11 | 2001-12-11 | Lebensmittel- oder Tierfutterzusammensetzung enthaltend Pflanzenextracte für den Erhalt der Knochen und die Vorbeugung oder Heilung von Knochenkrankheiten |
| PCT/EP2002/013174 WO2003053166A1 (en) | 2001-12-11 | 2002-12-10 | Food or pet food composition containing plant extract for bone health |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20042150L NO20042150L (no) | 2004-09-03 |
| NO326796B1 true NO326796B1 (no) | 2009-02-16 |
Family
ID=8181406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20042150A NO326796B1 (no) | 2001-12-11 | 2004-05-25 | Naeringsmiddel- eller dyrefôrsammensetning som innheholder planteekstrakt for a forebygge benresorpsjon og fremme bendannelse samt anvendelse av en plante eller planteekstrakt |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20050106215A1 (de) |
| EP (2) | EP1325682A1 (de) |
| JP (2) | JP4237063B2 (de) |
| KR (1) | KR20040073449A (de) |
| CN (1) | CN100473291C (de) |
| AT (1) | ATE410076T1 (de) |
| AU (1) | AU2002358530B2 (de) |
| BR (1) | BR0214865A (de) |
| CA (1) | CA2466617A1 (de) |
| CO (1) | CO5590865A2 (de) |
| DE (1) | DE60229286D1 (de) |
| ES (1) | ES2314122T3 (de) |
| HK (1) | HK1076010A1 (de) |
| IL (2) | IL161737A0 (de) |
| MX (1) | MXPA04005582A (de) |
| NO (1) | NO326796B1 (de) |
| PL (1) | PL369998A1 (de) |
| PT (1) | PT1455600E (de) |
| RU (1) | RU2316231C2 (de) |
| WO (1) | WO2003053166A1 (de) |
| ZA (1) | ZA200405451B (de) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60238663D1 (de) | 2002-04-05 | 2011-02-03 | Nestle Sa | Zusammensetzungen und Verfahren zur Verbesserung von Lipidassimilation in Haustieren |
| EP1687008B1 (de) | 2003-11-21 | 2024-04-17 | Société des Produits Nestlé S.A. | Nahrungsmittelzubereitung enthaltend glucosamine |
| TW200521171A (en) | 2003-12-26 | 2005-07-01 | Toshiba Kk | Resin particles and resin layer containing metal micro particles, its forming method and circuit base board |
| US7670742B2 (en) | 2005-03-15 | 2010-03-02 | Ricoh Company, Ltd. | Recording material, toner, liquid developer and image forming method using the same |
| JP5436895B2 (ja) * | 2009-03-13 | 2014-03-05 | サントリーホールディングス株式会社 | 水抽出コンドロイチンおよびミルク香料を含む経口製剤 |
| WO2011139382A2 (en) * | 2010-05-06 | 2011-11-10 | James Wade | Dandelion processes, compositions and products |
| RU2509569C2 (ru) * | 2011-07-05 | 2014-03-20 | Общество С Ограниченной Ответственностью "Парафарм" | Композиция для лечения и предупреждения остеоартрита и остеоартроза суставов |
| CN104684414A (zh) | 2011-12-19 | 2015-06-03 | 可口可乐公司 | 纯化甜叶菊醇糖苷的方法和其用途 |
| US10047034B2 (en) * | 2012-05-16 | 2018-08-14 | Prairie Berry Europe Gmbh | Polyhydroxylated pentacyclic triterpene acids as HMG-COA reductase inhibitors |
| EP2934181B1 (de) | 2012-12-19 | 2019-09-25 | The Coca-Cola Company | Zusammensetzungen und verfahren zur verbesserung der löslichkeit von rebaudiosid-x |
| US20140272068A1 (en) | 2013-03-14 | 2014-09-18 | Indra Prakash | Beverages containing rare sugars |
| US20160029677A1 (en) | 2013-03-15 | 2016-02-04 | The Coca-Cola Company | Novel glucosyl steviol glycosides, their compositions and their purification |
| US10570164B2 (en) | 2013-03-15 | 2020-02-25 | The Coca-Cola Company | Steviol glycosides, their compositions and their purification |
| US10905146B2 (en) | 2013-07-12 | 2021-02-02 | The Coca-Cola Company | Compositions for improving rebaudioside M solubility |
| CN103461805B (zh) * | 2013-08-18 | 2014-07-16 | 青岛福加德面粉有限公司 | 一种可用于骨质疏松病人食用的面粉 |
| US20170275666A1 (en) | 2014-08-19 | 2017-09-28 | The Coca-Cola Company | Methods for Preparing Rebaudioside I and Uses |
| US11230567B2 (en) | 2014-09-02 | 2022-01-25 | Purecircle Usa Inc. | Stevia extracts enriched in rebaudioside D, E, N and/or O and process for the preparation thereof |
| KR20160054668A (ko) * | 2014-11-06 | 2016-05-17 | 주식회사 엘지생활건강 | 포공영 추출물을 포함하는 히알루론산 생성 촉진용 조성물과 이의 이용 |
| WO2016086233A1 (en) | 2014-11-29 | 2016-06-02 | The Coca-Cola Company | Novel diterpene glycosides, compositions and purification methods |
| CN107613785A (zh) | 2015-05-20 | 2018-01-19 | 嘉吉公司 | 糖苷组合物 |
| EP3340807A4 (de) | 2015-08-27 | 2019-05-08 | PureCircle SDN BHD | Steviaextrakte |
| EP4190172A1 (de) | 2015-10-02 | 2023-06-07 | The Coca-Cola Company | Süssmittelzubereitung enthaltend steviolglycosidsüssstoffe mit verbesserten geschmacksprofilen |
| CN118697017A (zh) | 2016-03-28 | 2024-09-27 | 可口可乐公司 | 具有类黄酮的甜菊醇糖苷或罗汉果苷甜味剂的甜度和味道改善 |
| CN109219355B (zh) | 2016-04-06 | 2023-03-07 | 可口可乐公司 | 甜菊醇糖苷或罗汉果苷甜味剂的甜度和味道改善 |
| WO2018067683A1 (en) | 2016-10-04 | 2018-04-12 | The Coca-Cola Company | Diterpene glycosides containing an ent-atisene core, compositions and methods |
| CA3041123A1 (en) | 2016-10-20 | 2018-04-26 | The Coca-Cola Company | Diterpene glycosides isolated from stevia, compositions and methods |
| WO2018102648A1 (en) | 2016-12-01 | 2018-06-07 | Purecircle Usa Inc. | Stevia plant and uses thereof |
| WO2018138607A1 (en) * | 2017-01-24 | 2018-08-02 | Nestec Sa | Compositions comprising anti-fel d1 antibodies and methods for reducing at least one symptom of human allergy to cats |
| MX2019012615A (es) | 2017-04-25 | 2020-02-05 | Coca Cola Co | Mejora del dulzor y sabor de edulcorantes de glicosido de esteviol y mogrosido con dihidrochalconas. |
| RU2674590C1 (ru) * | 2017-06-14 | 2018-12-11 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Уральский государственный экономический университет" (УрГЭУ) | Специализированный пищевой продукт для поддержания суставов и дермы и способ его получения |
| CN111295101B (zh) | 2017-06-27 | 2023-09-01 | 可口可乐公司 | 口服甜味剂组合物和方法 |
| CN111372468A (zh) | 2017-10-06 | 2020-07-03 | 嘉吉公司 | 甜菊醇糖苷溶解度增强剂 |
| EP3787417B1 (de) | 2018-04-30 | 2024-02-28 | The Coca-Cola Company | Verfahren zur verbesserung der löslichkeit von steviolglycosidgemischen und verwendungen |
| EP3790407A4 (de) | 2018-05-08 | 2022-03-30 | EPC Natural Products Co., Ltd. | Süssstoff-und aromazusammensetzungen, herstellungsverfahren und verwendungsverfahren dafür |
| WO2020123067A2 (en) | 2018-10-12 | 2020-06-18 | Epc Natural Products Co., Ltd. | Sweetener and flavor compositions, methods of making and methods of use thereof |
| KR102167537B1 (ko) | 2018-12-21 | 2020-10-19 | (주)에이앤바이오 | 반려동물 전용 슬개골 탈구 예방과 근육 강화를 위한 조성물 |
| KR102087792B1 (ko) * | 2019-01-23 | 2020-03-11 | 심기호 | 애완동물용 건강식품 제조방법 |
| WO2020210118A1 (en) | 2019-04-06 | 2020-10-15 | Cargill, Incorporated | Sensory modifiers |
| CA3155670A1 (en) | 2019-09-27 | 2021-04-01 | The Coca-Cola Company | Sweetener blends with improved taste |
| KR20240046918A (ko) | 2021-09-01 | 2024-04-11 | 더 코카콜라 컴파니 | 카페인 및/또는 이의 유도체 및 폴리페놀을 포함하는 조성물 및 방법 |
| WO2024081959A2 (en) | 2022-10-14 | 2024-04-18 | The Coca-Cola Company | Methods and compositions for improving cognitive and mood functions |
| WO2024186617A1 (en) | 2023-03-03 | 2024-09-12 | The Coca-Cola Company | Compositions containing gamma-aminobutyric acid and methods for improving cognitive functions, mood, and alertness |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2102460C1 (ru) * | 1996-05-13 | 1998-01-20 | Уфимский винодельческий завод | Композиция ингредиентов для бальзама "капова пещера" |
| CN1057218C (zh) * | 1996-07-01 | 2000-10-11 | 谢景龙 | 一种用于治疗疮疡及外伤感染的中药制剂及其制备方法 |
| US5962517A (en) * | 1997-01-31 | 1999-10-05 | Murad; Howard | Pharmaceutical compositions and methods for treating acne |
| FR2768621B1 (fr) * | 1997-09-22 | 2000-04-07 | Oreal | Utilisation d'un extrait d'au moins un vegetal de la famille des rosacees |
| DE19814725A1 (de) * | 1998-04-02 | 1999-10-07 | Michael O Ruepp | Verwendung von Echinacea-pallida und Echinacea angustifolia-Extrakten; Löwenzahn-/Taraxacum)-Extrakten; Spitzwegerich-(Plantago)-Extrakten |
| GB2363714B (en) * | 1998-04-23 | 2004-03-03 | Vladimir Leko | Herbal composition and medicament against diabetes mellitus type II manufactured thereof |
| US20010024664A1 (en) * | 1999-03-19 | 2001-09-27 | Obukowicz Mark G. | Selective COX-2 inhibition from edible plant extracts |
| AU776783B2 (en) * | 1999-07-09 | 2004-09-23 | Sun Farm Corporation | Method of treating malignancies and viral infections and improving immune function with a dietary supplement |
| US6309675B1 (en) * | 1999-07-21 | 2001-10-30 | Nancy Laning Sobczak | Therapeutic composition including plantain and aloe vera for treatment of arthritis and other afflictions |
| US6333056B1 (en) * | 2000-08-14 | 2001-12-25 | Ralph Stanley Robinson | Herbal-based pharmaceutical formulations |
-
2001
- 2001-12-11 EP EP01204839A patent/EP1325682A1/de not_active Withdrawn
-
2002
- 2002-12-10 PL PL02369998A patent/PL369998A1/xx unknown
- 2002-12-10 DE DE60229286T patent/DE60229286D1/de not_active Expired - Fee Related
- 2002-12-10 CA CA002466617A patent/CA2466617A1/en not_active Abandoned
- 2002-12-10 AU AU2002358530A patent/AU2002358530B2/en not_active Ceased
- 2002-12-10 ES ES02792794T patent/ES2314122T3/es not_active Expired - Lifetime
- 2002-12-10 IL IL16173702A patent/IL161737A0/xx unknown
- 2002-12-10 PT PT02792794T patent/PT1455600E/pt unknown
- 2002-12-10 WO PCT/EP2002/013174 patent/WO2003053166A1/en active Application Filing
- 2002-12-10 MX MXPA04005582A patent/MXPA04005582A/es active IP Right Grant
- 2002-12-10 RU RU2004121170/13A patent/RU2316231C2/ru not_active IP Right Cessation
- 2002-12-10 KR KR10-2004-7008460A patent/KR20040073449A/ko not_active Application Discontinuation
- 2002-12-10 US US10/497,932 patent/US20050106215A1/en not_active Abandoned
- 2002-12-10 EP EP02792794A patent/EP1455600B1/de not_active Expired - Lifetime
- 2002-12-10 CN CNB02824513XA patent/CN100473291C/zh not_active Expired - Fee Related
- 2002-12-10 BR BR0214865-0A patent/BR0214865A/pt not_active IP Right Cessation
- 2002-12-10 JP JP2003553933A patent/JP4237063B2/ja not_active Expired - Fee Related
- 2002-12-10 AT AT02792794T patent/ATE410076T1/de not_active IP Right Cessation
-
2004
- 2004-05-03 IL IL161737A patent/IL161737A/en not_active IP Right Cessation
- 2004-05-25 NO NO20042150A patent/NO326796B1/no not_active IP Right Cessation
- 2004-06-08 CO CO04053696A patent/CO5590865A2/es not_active Application Discontinuation
- 2004-07-08 ZA ZA200405451A patent/ZA200405451B/en unknown
-
2005
- 2005-09-16 HK HK05108132.7A patent/HK1076010A1/xx not_active IP Right Cessation
-
2007
- 2007-12-20 JP JP2007329202A patent/JP4195904B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| IL161737A0 (en) | 2005-11-20 |
| HK1076010A1 (en) | 2006-01-06 |
| EP1325682A1 (de) | 2003-07-09 |
| EP1455600A1 (de) | 2004-09-15 |
| US20050106215A1 (en) | 2005-05-19 |
| CO5590865A2 (es) | 2005-12-30 |
| IL161737A (en) | 2009-02-11 |
| NO20042150L (no) | 2004-09-03 |
| JP2005512553A (ja) | 2005-05-12 |
| ES2314122T3 (es) | 2009-03-16 |
| RU2316231C2 (ru) | 2008-02-10 |
| JP4195904B2 (ja) | 2008-12-17 |
| ATE410076T1 (de) | 2008-10-15 |
| CN100473291C (zh) | 2009-04-01 |
| CN1602158A (zh) | 2005-03-30 |
| JP4237063B2 (ja) | 2009-03-11 |
| AU2002358530A1 (en) | 2003-07-09 |
| WO2003053166A1 (en) | 2003-07-03 |
| DE60229286D1 (de) | 2008-11-20 |
| RU2004121170A (ru) | 2006-01-10 |
| EP1455600B1 (de) | 2008-10-08 |
| BR0214865A (pt) | 2004-12-14 |
| CA2466617A1 (en) | 2003-07-03 |
| ZA200405451B (en) | 2005-07-08 |
| PT1455600E (pt) | 2008-11-25 |
| KR20040073449A (ko) | 2004-08-19 |
| MXPA04005582A (es) | 2004-12-06 |
| AU2002358530B2 (en) | 2008-08-07 |
| PL369998A1 (en) | 2005-05-16 |
| JP2008131946A (ja) | 2008-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO326796B1 (no) | Naeringsmiddel- eller dyrefôrsammensetning som innheholder planteekstrakt for a forebygge benresorpsjon og fremme bendannelse samt anvendelse av en plante eller planteekstrakt | |
| EP2286675B1 (de) | Zusammensetzung für die Förderung des Knochenwachstums und die Erhaltung der Knochengesundheit |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |